Iovance Biotherapeutics
IOVA
IOVA
245 hedge funds and large institutions have $2.96B invested in Iovance Biotherapeutics in 2021 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 95 increasing their positions, 84 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.55% less ownership
Funds ownership: 101.9% → 99.36% (-2.5%)
24% less capital invested
Capital invested by funds: $3.88B → $2.96B (-$921M)
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
Holders
245
Holding in Top 10
3
Calls
$76.2M
Puts
$17.6M
Top Buyers
| 1 | +$44.2M | |
| 2 | +$23.2M | |
| 3 | +$16.4M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$13.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$13.5M |
Top Sellers
| 1 | -$84.9M | |
| 2 | -$27.2M | |
| 3 | -$27M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$26M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
-$23.6M |